B. Riley Wealth Advisors’s Filana Therapeutics FLNA Stock Holding History

B. Riley Wealth Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,895	Closed	-$205K	–	1579
2022 Q3	$205K	Buy	+4,895	New	+$132K	0.01%	1218
2021 Q3	–	Sell	-8,014	Closed	-$685K	–	1461
2021 Q2	$685K	Buy	+8,014	New	+$429K	0.02%	647

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCM

Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

B. Riley Wealth Advisors's FLNA Position: Q4 2022 in Review

B. Riley Wealth Advisors sold out of Filana Therapeutics (FLNA) in Q4 2022, closing a stake of 4,895 shares — an estimated $205K sold.

B. Riley Wealth Advisors first reported a position in FLNA in Q2 2021 and held it in 2 quarters. The position peaked at $685K in Q2 2021. 153 funds tracked by Wall St. Rank hold FLNA as of Q4 2022.

B. Riley Wealth Advisors reported no remaining Filana Therapeutics position as of Q4 2022 after selling out during the quarter.
B. Riley Wealth Advisors sold 4,895 Filana Therapeutics shares in Q4 2022, an estimated $205K.
B. Riley Wealth Advisors first reported a position in Filana Therapeutics in Q2 2021 and held it in 2 quarters.
B. Riley Wealth Advisors's Filana Therapeutics position peaked at $685K in Q2 2021.
153 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2022.

Based on B. Riley Wealth Advisors's 13F filing for Q4 2022, filed 21 Feb 2023.